Docetaxel (D) plus high-dose calcitriol versus D plus prednisone (P) for patients (Pts) with progressive castration-resistant prostate cancer (CRPC): Results from the phase III ASCENT2 trial Meeting Abstract

  

Authors:	Scher, H. I.; Chi, K. N.; De Wit, R.; Berry, W. R.; Albers, P.; Henick, B.; Venner, P.; Heidenreich, A.; Chu, L.; Heller, G.
Abstract Title:	Docetaxel (D) plus high-dose calcitriol versus D plus prednisone (P) for patients (Pts) with progressive castration-resistant prostate cancer (CRPC): Results from the phase III ASCENT2 trial
Meeting Title:	46th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	28
Issue:	15 Suppl.
Meeting Dates:	2010 Jun 4-8
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2010-05-20
Start Page:	344s
Language:	English
ACCESSION:	WOS:000208852003636
DOI:	10.1200/jco.2010.28.15_suppl.4509
PROVIDER:	wos
Notes:	Meeting Abstract: 4509 -- S -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/129558